QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

BLFS

QT72BioLife Solutions, Inc.
NASDAQ·Healthcare·Medical - Instruments & Supplies·USA
Latest market price
26.04
+0.46+1.80%
OverviewShort InterestFilings
BLFSQT72BioLife Solutions, Inc.·NASDAQ
OverviewShort InterestFilings
26.04+1.80%
TA
Loading chart...
Screen all →
BDX+1.67%$143.98ALC+0.84%$64.68MDLN-1.32%$35.94WST+1.35%$327.95COO+1.32%$65.91BAX+2.58%$19.89ATR+0.28%$120.32RGEN-1.15%$132.02
Snapshot
Index-P/E-EPS (ttm)-0.22
Insider Own24.01%
Shs Outstand48.86M
Perf Week-2.11%
Market Cap1.25BForward P/E80.38EPS next Y0.32Insider Trans-2.67%Shs Float-Perf Month12.97%
Enterprise Value1.24BPEG0.17EPS next Q0.03Inst Own-Short Float-Perf Quarter33.33%
Income-10623068.00P/S12.53EPS this Y164.77%Inst Trans-Short Ratio-Perf Half Y5.81%
Sales99.77MP/B3.33EPS next Y127.34%ROA-2.62%Short Interest-Perf YTD7.69%
Book/sh7.61P/C69.26EPS next 5Y88.26%ROE-2.91%52W High29.62 -12.09%Perf Year19.78%
Cash/sh1.66P/FCF-EPS past 3/5Y-ROIC-2.81%52W Low17.86 45.80%Perf 3Y-
Dividend Est.-EV/EBITDA-166.46Sales past 3/5Y8.10% 14.87%Gross Margin63.89%Volatility3.66% 3.54%Perf 5Y-
Dividend TTM-EV/Sales12.45EPS Y/Y TTM51.97%Oper. Margin-10.91%ATR (14)1.30Perf 10Y-
Dividend Ex-Date-Quick Ratio5.50Sales Y/Y TTM21.95%Profit Margin-10.52%RSI (14)55.80Recom2.00
Dividend Gr. 3/5Y-Current Ratio7.30EPS Q/Q-SMA200.12%Beta1.44Target Price34.00
Payout0.00%Debt/Eq0.04Sales Q/Q16.67%SMA5011.83%Rel Volume1.91Prev Close25.58
Employees159LT Debt/Eq0.03EarningsAug 06SMA2008.61%Avg Volume586.26KPrice26.04
IPO DateNov 22, 1989Option/ShortYes / YesEPS/Sales Surpr.300.00% 7.69%Net Debt/EBITDA1.07Volume1,117,751Change1.80%
Analyst Ratings
DateActionAnalystRatingTarget
Jan-05-26ReiteratedNorthland Securities$34
Nov-24-25ReiteratedH.C. WainwrightBuy$30 → $32
Mar-05-25ReiteratedH.C. WainwrightBuy$27 → $30
Nov-15-24ReiteratedStephens$30
Aug-12-24ReiteratedCraig-HallumBuy$30
May-13-24UpgradeBenchmarkHold → Buy
Apr-04-24ReiteratedJefferies$22
Apr-25-22UpgradeOppenheimerPerform → Outperform
May-14-21DowngradeBenchmarkBuy → Hold
Mar-23-21UpgradeBenchmarkHold → Buy
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue1009682
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A363429
Gross Profit636254
Selling, General and Administrative Excl. Other575550
Research and Development988
Other Operating Expense8113
Operating Income-11-1-7
Interest Expense131
Unusual Expense
———
Non-Operating Income (Expense)100
Net Income Before Taxes-11-12-11
Income Taxes000
Consolidated Net Income-10-12-20
Net Income From Continuing Operations-10-12-11
Net Income-10-12-20
EPS (Recurring)-0.22-0.25-0.44
EPS (Basic, Before Extraordinaries)-0.22-0.25-0.44
EPS (Diluted)-0.22-0.25-0.44
EBITDA-742
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio12.5012.09—
Gross Margin63.0064.5865.85
Operating Margin-11.00-1.04-8.54
Net Margin-10.00-12.50-24.39
Shares Outstanding484846
Market Capitalization1,2501,161—
Operating Lease Expense
———
Insider Trading Volume
$30.31$27.30$24.28$21.26$18.25● Close Price0.00M7.03M14.06M21.09M28.13MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Casdin Partners Master Fund, L.P.10% OwnerMay 21 '26Sale23.70650,00015,405,0004,757,165May 21 12:00 AM
Casdin Partners Master Fund, L.P.10% OwnerMay 20 '26Sale23.70250,0005,925,0005,407,165May 21 12:00 AM
Casdin Partners Master Fund, L.P.10% OwnerMay 19 '26Sale22.65300,0006,795,0005,657,165May 21 12:00 AM
Foster Karen A.Chief Quality and OperationsMar 23 '26Sale19.172,57749,401108,758Mar 31 12:00 AM
Foster Karen A.Chief Quality and OperationsMar 09 '26Sale20.0050010,000113,242Mar 09 12:00 AM
Foster Karen A.Chief Quality and OperationsMar 05 '26Sale20.1596,9231,952,998113,742Mar 09 12:00 AM
Foster Karen A.Chief Quality and OperationsMar 03 '26Sale20.744188,669210,665Mar 05 12:00 AM
Mathew Aby J.EVP & Chief Scientific OfficerMar 03 '26Sale20.7452910,971392,937Mar 05 12:00 AM
Wichterman TroyChief Financial OfficerMar 03 '26Sale20.7458812,195220,649Mar 05 12:00 AM
Aebersold SarahChief Human Resources OfficerMar 03 '26Sale20.742194,54293,360Mar 05 12:00 AM
Berard ToddChief Marketing OfficerMar 03 '26Sale20.743537,321165,940Mar 05 12:00 AM
Werner SeanChief Technology OfficerMar 03 '26Sale20.741112,30249,932Mar 05 12:00 AM
Wichterman TroyChief Financial OfficerJan 06 '26Sale25.5999025,334150,746Jan 08 12:00 AM
Foster Karen A.Chief Quality and OperationsJan 06 '26Sale25.593358,573191,984Jan 08 12:00 AM
Aebersold SarahChief Human Resources OfficerJan 06 '26Sale25.592416,16775,765Jan 08 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR